Plasma leptin levels and free leptin index in women with Alzheimer's disease

Neuropeptides

Volumn 52, Issue , 2015, Pages 73-78

  Baranowska Bik, Agnieszka ^a   Bik, Wojciech ^b   Styczynska, Maria ^c   Chodakowska Zebrowska, Malgorzata ^d   Barcikowska, Maria ^c   Wolinska Witort, Ewa ^b   Kalisz, Malgorzata ^b   Martynska, Lidia ^b   Baranowska, Boguslawa ^e  

^a BIELANSKI HOSPITAL   (Poland)

^b MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

^c MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^d MSW and A Hospital   (Poland)

^e MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Alzheimer's disease; Free leptin index; Leptin; Leptin receptor

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; LEPTIN RECEPTOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SOLUBLE LEPTIN RECEPTOR; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

AGED; ALZHEIMER DISEASE; ANALYTICAL PARAMETERS; ARTICLE; CHOLESTEROL BLOOD LEVEL; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; FREE LEPTIN INDEX; GLUCOSE BLOOD LEVEL; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; IMMUNORADIOMETRIC ASSAY; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MATHEMATICAL MODEL; METABOLISM; MINI MENTAL STATE EXAMINATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; BODY MASS; MENTAL HEALTH; PSYCHOLOGY;

AGED; ALZHEIMER DISEASE; BODY MASS INDEX; FEMALE; HUMANS; LEPTIN; MENTAL STATUS SCHEDULE; RECEPTORS, LEPTIN;

EID: 84949805558     PISSN: 01434179     EISSN: 15322785     Source Type: Journal    
DOI: 10.1016/j.npep.2015.05.006     Document Type: Article

References (44)

1. Arnoldussen I.A., Kiliaan A.J., Gustafson D.R. Obesity and dementia: adipokines interact with the brain. Eur. Neuropsychopharmacol. 2014, 24:1982-1999.
2. Beccano-Kelly D., Harvey J. Leptin: a novel therapeutic target in Alzheimer's disease?. Int. J. Alzheimers Dis. 2012, 2012:594137.
3. Bigalke B., Schreitmüller B., Sopova K., Paul A., Stransky E., Gawaz M., Stellos K., Laske C. Adipocytokines and CD34 progenitor cells in Alzheimer's disease. PLoS One 2011, 6:e20286.
4. Blennow K., de Leon M.J., Zetterberg H. Alzheimer's disease. Lancet 2006, 368:387-403.
5. Cai H., Cong W.N., Ji S., Rothman S., Maudsley S., Martin B. Metabolic dysfunction in Alzheimer's disease and related neurodegenerative disorders. Curr. Alzheimer Res. 2012, 9:5-17.
6. de la Monte S.M. Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease. Curr. Alzheimer Res. 2012, 9:35-66.
7. Dietrich M.O., Spuch C., Antequera D., Rodal I., de Yébenes J.G., Molina J.A., Bermejo F., Carro E. Megalin mediates the transport of leptin across the blood-CSF barrier. Neurobiol. Aging 2008, 29:902-912.
8. Erol A. An integrated and unifying hypothesis for the metabolic basis of sporadic Alzheimer's disease. J. Alzheimers Dis. 2008, 13:241-253.
9. Farr S.A., Banks W.A., Morley J.E. Effects of leptin on memory processing. Peptides 2006, 27:1420-1425.
10. Gomes S., Martins I., Fonseca A.C., Oliveira C.R., Resende R., Pereira C.M. Protective effect of leptin and ghrelin against toxicity induced by Amyloid-β oligomers in a hypothalamic cell line. Neuroendocrinology 2014, 26:176-185.
11. Gorska E., Popko K., Stelmaszczyk-Emmel A., Ciepiela O., Kucharska A., Wasik M. Leptin receptors. Eur. J. Med. Res. 2010, 15(Suppl 2):50-54.
12. Gustafson D.R., Backman K., Lissner L., Carlsson L., Waern M., Ostling S., Guo X., Bengtsson C., Skoog I. Leptin and dementia over 32years-The Prospective Population Study of Women. Alzheimers Dement. 2012, 8:272-277.
13. Harvey J., Shanley L.J., O'Malley D., Irving A.J. Leptin: a potential cognitive enhancer?. Biochem. Soc. Trans. 2005, 33:1029-1032.
14. Holden K.F., Lindquist K., Tylavsky F.A., Rosano C., Harris T.B., Yaffe K., Health ABC study Serum leptin level and cognition in the elderly: findings from the Health ABC Study. Neurobiol. Aging 2009, 30:1483-1489.
15. Intebi A.D., Garau L., Brusco I., Pagano M., Gaillard R.C., Spinedi E. Alzheimer's disease patients display gender dimorphism in circulating anorectic adipokines. Neuroimmunomodulation 2002-2003, 10:351-358.
16. Irving A.J., Harvey J. Leptin regulation of hippocampal synaptic function in health and disease. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2013, 369:20130155.
17. Johnston J.M., Hu W.T., Fardo D.W., Greco S.J., Perry G., Montine T.J., Trojanowski J.Q., Shaw L.M., Ashford J.W., Tezapsidis N. Low plasma leptin in cognitively impaired ADNI subjects: gender differences and diagnostic and therapeutic potential. Curr. Alzheimer Res. 2014, 11:165-174.
18. Khemka V.K., Bagchi D., Bandyopadhyay K., Bir A., Chattopadhyay M., Biswas A., Basu D., Chakrabarti S. Altered serum levels of adipokines and insulin in probable Alzheimer's Disease. J. Alzheimers Dis. 2014, 41:525-533.
19. Lee E.B. Obesity, leptin, and Alzheimer's disease. Ann. N. Y. Acad. Sci. 2011, 1243:15-29.
20. Lieb W., Beiser A.S., Vasan R.S., Tan Z.S., Au R., Harris T.B., Roubenoff R., Auerbach S., DeCarli C., Wolf P.A., Seshadri S. Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging. JAMA 2009, 302:2565-2572.
21. Luchsinger J.A. Adiposity, hyperinsulinemia, diabetes and Alzheimer's disease: an epidemiological perspective. Eur. J. Pharmacol. 2008, 585:119-129.
22. Luchsinger J.A., Cheng D., Tang M.X., Schupf N., Mayeux R. Central obesity in the elderly is related to late-onset Alzheimer disease. Alzheimer Dis. Assoc. Disord. 2012, 26:101-105.
23. Martins I., Gomes S., Costa R.O., Otvos L., Oliveira C.R., Resende R., Pereira C.M. Leptin and ghrelin prevent hippocampal dysfunction induced by Aβ oligomers. Neuroscience 2013, 241:41-51.
24. Marwarha G., Raza S., Meiers C., Ghribi O. Leptin attenuates BACE1 expression and amyloid-beta genesis via the activation of SIRT1 signaling pathway. Biochim. Biophys. Acta 2014, 1842:1587-1595.
25. Matochik J.A., London E.D., Yildiz B.O., Ozata M., Caglayan S., DePaoli A.M., Wong M.L., Licinio J. Effect of leptin replacement on brain structure in genetically leptin-deficient adults. J. Clin. Endocrinol. Metab. 2005, 90:2851-2854.
26. Merlo S., Spampinato S., Canonico P.L., Copani A., Sortino M.A. Alzheimer's disease: brain expression of a metabolic disorder?. Trends Endocrinol. Metab. 2010, 21:537-544.
27. Myers M.G., Leibel R.L., Seeley R.J., Schwartz M.W. Obesity and leptin resistance: distinguishing cause from effect. Trends Endocrinol. Metab. 2010, 21:643-651.
28. Narita K., Kosaka H., Okazawa H., Murata T., Wada Y. Relationship between plasma leptin level and brain structure in elderly: a voxel-based morphometric study. Biol. Psychiatry 2009, 65:992-994.
29. Oania R., McEvoy L.K. Plasma leptin levels are not predictive of dementia in patients with mild cognitive impairment. Age Ageing 2015, 44:53-58.
30. Ott A., Stolk R.P., van Harskamp F., Pols H.A., Hofman A., Breteler M.M. Diabetes mellitus and the risk of dementia: the Rotterdam Study. Neurology 1999, 53:1937-1942.
31. Paz-Filho G.J., Babikian T., Asarnow R., Delibasi T., Esposito K., Erol H.K., Wong M.L., Licinio J. Leptin replacement improves cognitive development. PLoS One 2008, 3:e3098.
32. Paz-Filho G., Wong M.L., Licinio J. The procognitive effects of leptin in the brain and their clinical implications. Int. J. Clin. Pract. 2010, 64:1808-1812.
33. Power D.A., Noel J., Collins R., O'Neill D. Circulating leptin levels and weight loss in Alzheimer's disease patients. Dement. Geriatr. Cogn. Disord. 2001, 12:167-170.
34. Rios J.A., Cisternas P., Arrese M., Barja S., Inestrosa N.C. Is Alzheimer's disease related to metabolic syndrome? A Wnt signaling conundrum. Prog. Neurobiol. 2014, 121:125-146.
35. Rosenbaum M., Pietrobelli A., Vasselli J.R., Heymsfield S.B., Leibel R.L. Sexual dimorphism in circulating leptin concentrations is not accounted for by differences in adipose tissue distribution. Int. J. Obes. Relat. Metab. Disord. 2001, 25:1365-1371.
36. Scott M.M., Lachey J.L., Sternson S.M., Lee C.E., Elias C.F., Friedman J.M., Elmquist J.K. Leptin targets in the mouse brain. J. Comp. Neurol. 2009, 514:518-532.
37. Teunissen C.E., van der Flier W.M., Scheltens P., Duits A., Wijnstok N., Nijpels G., Dekker J.M., Blankenstein R.M., Heijboer A.C. Serum leptin is not altered nor related to cognitive decline in Alzheimer's disease. J. Alzheimers Dis. 2015, 44:809-813.
38. Tezapsidis N., Johnston J.M., Smith M.A., Ashford J.W., Casadesus G., Robakis N.K., Wolozin B., Perry G., Zhu X., Greco S.J., Sarkar S. Leptin: a novel therapeutic strategy for Alzheimer's disease. J. Alzheimers Dis. 2009, 16:731-740.
39. Theodoropoulou A., Metallinos I.C., Psyrogiannis A., Vagenakis G.A., Kyriazopoulou V. Ghrelin and leptin secretion in patients with moderate Alzheimer's disease. J. Nutr. Health Aging 2012, 16:472-477.
40. Warren M.W., Hynan L.S., Weiner M.F. Lipids and adipokines as risk factors for Alzheimer's disease. J. Alzheimers Dis. 2012, 29:151-157.
41. Whitmer R.A., Gunderson E.P., Quesenberry C.P., Zhou J., Yaffe K. Body mass index in midlife and risk of Alzheimer disease and vascular dementia. Curr. Alzheimer Res. 2007, 4:103-109.
42. Whitmer R.A., Gustafson D.R., Barrett-Connor E., Haan M.N., Gunderson E.P., Yaffe K. Central obesity and increased risk of dementia more than three decades later. Neurology 2008, 71:1057-1064.
43. Wilkinson M., Brown R., Imran S.A., Ur E. Adipokine gene expression in brain and pituitary gland. Neuroendocrinology 2007, 86:191-209.
44. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372:425-432.